Skip to main content

Year: 2026

Nexans Mixed Shareholders’ Meeting of May 21st, 2026

   Nexans Mixed Shareholders’ Meeting of May 21st, 2026 _PRESS RELEASE_ Paris La Défense, on May 21st, 2026 – Nexans Annual Shareholders’ Meeting, held today in La Défense, approved all 22 resolutions proposed by the Board of Directors. The voting results are available on the Nexans website. The Shareholders’ Meeting was broadcast live in French and English, and a replay will be available shortly on this same website. The shareholders approved in particular :The distribution of a dividend of 2.90 euros per share, up 11.5% compare to the previous year, which will be detached on May 25th, 2026 and paid on May 27th, 2026; The renewal of the terms of office of Laura Bernardelli and Anne Lebel as independent Directors; and The appointment of Antonio Cammisecra and Thierry Fournier as independent Directors.Following the Shareholders’...

Continue reading

Anoto exits exclusive supply and licence arrangement with KAIT and launches education technology platform

Anoto Group AB (publ) (“Anoto” or the “Company”) today announces the launch of a new education technology product and strategy. The Company is returning to EdTech, one of its foundational markets: digital assessment and classroom learning, addressing national exam authorities, school districts, universities and private educational institutions that need to combine the established benefits of pen-and-paper examinations with digital infrastructure for capture, archiving and grading. Anoto’s launch product is the inq exam platform. Candidates write with ink on paper; exam authorities receive real-time visibility of every stroke, secure cloud-based archiving, and the option of AI-assisted grading. The platform supports deployments from a single classroom to a national examination authority, in either managed-cloud...

Continue reading

The European Medicines Agency Accepts Teva’s Marketing Authorization Application for Olanzapine Long-Acting Injectable (TEV-‘749) for the Treatment of Schizophrenia in Adults

The olanzapine long-acting injectable (TEV-’749) is designed to deliver the efficacy of olanzapine in a subcutaneous formulation1 administered every four weeks. If approved, TEV-‘749 could help fill a significant unmet need in available schizophrenia treatment options by addressing the lack of a viable long-acting olanzapine formulation. Teva is committed to advancing this innovative treatment option, strengthening its scientific leadership in complex neurological conditions as part of its Pivot to Growth strategy.TEL AVIV, Israel and PARIS, May 21, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE: and TASE: TEVA) and Medincell (Euronext: MEDCL), today announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application...

Continue reading

Greened street furniture: JCDecaux confirms the benefits of this experiment

Greened street furniture: JCDecaux confirms the benefits of this experiment Paris, 21 May 2026 – For the World Biodiversity Day on 22 May, JCDecaux SE (Euronext Paris: DEC), the number one outdoor advertising company worldwide, together with the Ligue pour la Protection des Oiseaux (LPO – French League for the Protection of Birds), presents the promising results of its greening experiment based on 19 items of street furniture. The initiative has been running since April 2024 between the Jardin du Luxembourg and the Jardin des Plantes in Paris (France). As part of a broader strategy to create ecological continuity between parks and tree-lined areas, the greened JCDecaux street furniture promotes micro-ecosystems that are home to a wide variety of plant species, insects and birds. This initiative is proving to be effective by tackling the...

Continue reading

Eramet generated €2.5bn in economic contributions in 2025, with high levels in Gabon and Senegal

Paris, 21 May 2026 at 6:45pm PRESS RELEASE Eramet generated €2.5bn in economic contributions in 2025, with high levels in Gabon and SenegalThe Eramet Group maintained a high level of economic contributions in its host countries, with €2.5bn in economic contributions in 2025, close to the 2024 level (€2.7bn), reflecting the continuation of its commitments in local territories.Contributions reached particularly high levels in Gabon and Senegal, increasing respectively from €753.3m to €853.1m and from €185.4m to €229.7m.In Argentina, Eramet maintained a significant economic contribution of €230.9m. The Group’s initiatives benefited more than 314,000 people in total, up year-on-year, reflecting the expanded reach of the projects implemented.The Group’s economic contribution mainly relies on local procurement and subcontracting...

Continue reading

Netskope Announces Integration With Claude’s Compliance API to Strengthen Data Security and Governance

Integration provides visibility and advanced security controls for use of Anthropic’s Claude, supporting regulatory compliance for enterprise customers SANTA CLARA, Calif., May 21, 2026 (GLOBE NEWSWIRE) — Netskope (NASDAQ: NTSK), a leader in modern security and networking for the cloud and AI era, today announced a key integration with the Claude Compliance API. With this, organizations can now connect Claude Enterprise directly into the enhanced AI security features of the Netskope One platform, including full asset, identity and activity visibility, robust policy enforcement, advanced data security, and comprehensive security posture management. According to the Netskope AI Index – the authoritative source on the enterprise use and adoption of AI worldwide – Anthropic’s Claude grew from 56.2% to 94.9% adoption...

Continue reading

Valeo Shareholders’ meeting 2026

Valeo Shareholders’ Meeting 2026May 21, 2026 — Paris, France — Valeo’s Shareholders’ Meeting was held today, under the chairmanship of Gilles Michel, Chairman of the Board of Directors. All the resolutions were adopted.  The shareholders approved the financial statements for the year ended December 31, 2025 as well as a dividend distribution of 0.44 euro per share. The ex-dividend date is set at May 26, 2026, and the record date at May 27, 2026. The dividend will be paid on May 28, 2026. The Shareholders’ Meeting approved the renewal of the term of office of Gilles Michel as a director for a period of four years. The Board of Directors, which met following the Shareholders’ Meeting, unanimously reappointed Gilles Michel as Chairman of the Board of Directors. In accordance with the provisions of the articles of association...

Continue reading

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services OrganizationTevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services OrganizationWARREN, N.J., May 21, 2026 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent (“LoI”) to evaluate a potential transaction with a Management Services Organization (“MSO”). If consummated, the proposed transaction could expand Tevogen’s healthcare infrastructure capabilities and support the Company’s evolution into a revenue-generating healthcare enterprise comprised of Tevogen Bio, its biotechnology arm; Tevogen.AI, its technology arm; and, subject to completion of proposed transactions, a healthcare...

Continue reading

Availability of preparatory documents for the Shareholders’ meeting of June 16, 2026

Terms of availability of preparatory documents for the Shareholders’ Meeting on June 16, 2026 Saint-Rémy-lès-Chevreuse – May 21, 2026. GTT (Gaztransport et Technigaz) informs its shareholders that the annual (ordinary and extraordinary) Shareholders’ Meeting will be held on Tuesday June 16, 2026 at 2:00 pm at Domaine de St Paul, 102 route de Limours – 78470 Saint-Rémy-lès-Chevreuse, France. The preliminary notice of Meeting, including the agenda and the draft resolutions as well as the conditions and modalities of participation and voting at this Meeting, was published on the website of the Bulletin des Annonces Légales Obligatoires “BALO” (www.journal-officiel.gouv.fr/balo) on April 29, 2026. This notice can also be consulted on the GTT website (www.gtt.fr). The notice of Meeting will be published on May 29, 2026 on the BALO...

Continue reading

QUADIENT SA – Q1 2026 revenue: Strong bookings and usage growth accelerating Digital platform adoption. FY 2026 guidance confirmed

Quadient Q1 2026 revenue:Strong bookings and usage growth accelerating Digital platform adoption FY 2026 guidance confirmed Key highlightsQ1 2026 consolidated revenue of €243 million, down 1.9% on an organic basis(1) Sharp acceleration in Digital ARR(1)(2), up 16% on an annualized basis, with solid booking trends Significantly improved trends in Mail: yoy organic revenue change from -10.9% in Q4 2025 to -5.2% in Q1 2026, notably thanks to higher performance in North America Lockers subscription-related revenue(1) up 18%, representing 80% of total Lockers revenue, driven by further increase in usage, offset by high comparison basis for hardware sales Over the full year, Digital and Lockers expected to maintain solid subscription-related revenue growth, Mail trends to continue easing FY 2026 guidance confirmedParis, 21 May 2026 Quadient...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.